Peroxitech Therapeutics operates as a biopharmaceutical company.
Business Model:
Revenue: $0
Employees: 0-0
Address: 3401 Grays Ferry Avenue
City: Philadelphia
State: PA
Zip: 19146
Country: US
Peroxitech Therapeutics operates as a biopharmaceutical company developing PIP-2 to reverse acute lung injury (ALI) by targeting the cytokine storm cascade process.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2022 | Series A | $25M |
Perceptive Xontogeny Venture Fund |
5/2021 | Seed | - | 5/2021 | Seed Round | 1 | - |
Xontogeny Xontogeny |
12/2022 | Series A | 1 | $25M |
Xontogeny Xontogeny |
5/2021 | Seed | - |
Xontogeny, LLC Xontogeny, LLC |
5/2021 | Seed Round | 1 | - |
Xontogeny Xontogeny |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|